Derma Sciences (DSCI) Tops Q1 EPS by 6c

Derma Sciences (NASDAQ: DSCI) reported Q1 EPS of ($0.42), $0.06 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $19.5 million versus the consensus estimate of $19.89 million.

For earnings history and earnings-related data on Derma Sciences (DSCI) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• National Healthcare (NHC) Tops Q2 EPS by 174c
• Array Digital Infrastructure, Inc. (AD) Tops Q2 EPS by 345c